[治疗IgA病中的慢性病]
Deutsche medizinische Wochenschrift (1946)
|January 14, 2025
概括
本综述探讨了IgA病 (IgAN) 中慢性病 (CKD) 的治疗方法. 它涵盖了当前的治疗方法,如RAAS抑制剂和SGLT2抑制剂,以及缓慢IGAN进展的新兴选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- IgA脏病 (IgAN) 是最常见的原发性球球核脏炎.
- 它源于一种针对免疫球蛋白A (IgA) 抗体的自身免疫反应.
- 抗体能导致逐渐的损伤和末期病.
研究的目的:
- 为IGAN患者提供CKD当前和新兴治疗策略的全面概述.
- 为临床医生提供有关优化管理的信息,以减缓疾病进展和保持功能.
- 突出临床试验中的新型治疗点和药物.
主要方法:
- 对IgA脏病的已知和正在研究的治疗方法的审查.
- 讨论药理干预措施,包括RAAS抑制剂,SGLT2抑制剂和皮质类固醇.
- 检查非免疫抑制的选择和生活方式的修改.
主要成果:
- 目前的治疗方法旨在减少蛋白尿和保持功能.
- 像补充抑制剂和免疫调节剂这样的新兴疗法显示出有希望.
- 改变生活方式和非免疫抑制的选择可能有助于减缓疾病的进展.
结论:
- 在Igan中优化CKD管理需要采用多方面的方法.
- 新型疗法为IGAN患者提供了改善的预后.
- 对免疫调节和向治疗的持续研究至关重要.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Acute Kidney Injury IV: Diagnostic Studies and Prevention
8
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
Acute Kidney Injury V: Interprofessional Care
2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
Acute Kidney Injury III: Clinical Manifestations
2
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2
Chronic Kidney Disease I: Introduction
2
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
2
Acute Kidney Injury VI: Nursing Management
2
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
2


